Literature DB >> 8419600

Helium-oxygen mixture in respiratory distress syndrome: a double-blind study.

C Elleau1, R I Galperine, H Guenard, J L Demarquez.   

Abstract

In a randomized, controlled trial, the lungs of infants with respiratory distress syndrome were ventilated with either a helium-oxygen mixture or a nitrogen-oxygen mixture. In the helium-oxygen group, infants required a lower inspired oxygen concentration and a shorter duration of ventilation. There were also fewer deaths and fewer cases of bronchopulmonary dysplasia in the helium-oxygen group.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419600     DOI: 10.1016/s0022-3476(05)83506-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  Nasal continuous positive airway pressure with heliox in preterm infants with respiratory distress syndrome.

Authors:  Rafat Mosalli
Journal:  J Clin Neonatol       Date:  2012-07

2.  High flow nasal cannula (HFNC) with Heliox decreases diaphragmatic injury in a newborn porcine lung injury model.

Authors:  Romal K Jassar; Haritha Vellanki; Yan Zhu; Anne Hesek; Jordan Wang; Elena Rodriguez; Jichuan Wu; Thomas H Shaffer; Marla R Wolfson
Journal:  Pediatr Pulmonol       Date:  2014-02-05

3.  Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis.

Authors:  M F Gross; R M Spear; B M Peterson
Journal:  Crit Care       Date:  2000-04-13       Impact factor: 9.097

Review 4.  Noninvasive Ventilation with Heliox for Respiratory Distress Syndrome in Preterm Infant: A Systematic Review and Meta-Analysis.

Authors:  Chen Long; Wang Li; Li Wanwei; Li Jie; Shi Yuan
Journal:  Can Respir J       Date:  2016-11-22       Impact factor: 2.409

Review 5.  Neonatal Applications of Heliox: A Practical Review.

Authors:  Tomasz Szczapa; Patryk Kwapień; T Allen Merritt
Journal:  Front Pediatr       Date:  2022-03-10       Impact factor: 3.418

6.  A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion.

Authors:  S H Ahmedzai; E Laude; A Robertson; G Troy; V Vora
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.